Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
CIMA — Centro de Información de Medicamentos · Spain
- Updated
- Not provided for this source record
- Synchronized
- Oct 2, 2026
Medicine · Spain
XILONIBSA 20 mg/ml + 0,0125 mg/ml SOLUCION INYECTABLE
Injection
Home Med Cabinet
Updated · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) — Not provided for this source record
Synchronized
At a glance
- Active ingredient
- LIDOCAINA HIDROCLORURO — 20 mg
- EPINEFRINA BITARTRATO — 12.5 mg
- Pharmaceutical form Home Med Cabinet grouping
- Injection
- Availability in Spain
- All 2 packs marketed
Packs
XILONIBSA 20 mg/ml + 0,0125 mg/ml SOLUCION INYECTABLE, 100 cartuchos de 1,8 ml (émbolo con cavidad)
100 pcs
National code
Marketed606710Strength of this pack 20 mg
XILONIBSA 20 mg/ml + 0,0125 mg/ml SOLUCION INYECTABLE, 100 cartuchos de 1,8 ml (émbolo plano)
100 pcs
National code
Marketed615955Strength of this pack 20 mg
“Marketed” means the authority records the pack as placed on the market. It is not a statement about pharmacy stock.
Official documents
Documents open on the authority’s own site. Home Med Cabinet links to them and hosts no copy.
- Official
Opens on the authority’s own site
- Official
Summary of product characteristics
Opens on the authority’s own site
Registration
- Registration number
- 40858Official data
- Marketing authorisation holder
- LABORATORIOS INIBSA S.A.Official data
- Authorised
- May 1, 1965Official data
- Authority form code
- 197Official data
Classification
ATC classification is not published here yet
Publication rights for ATC codes and labels are still under review, and no classification is inferred for this record.